Iovance Biotherapeutics Inc (IOVA) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Iovance Biotherapeutics inc   (NASDAQ: IOVA)
 

Iovance Biotherapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Iovance Biotherapeutics Inc inventory turnover ratio, the Iovance Biotherapeutics Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 3.21 in the third quarter 2026, IOVA's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Iovance Biotherapeutics Inc in Sep 30 2026 quarter, has decreased to 114 days, compare to 118 days, in the Jun 30 2026 quarter.

Within Healthcare sector 121 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 995 in the second quarter 2026, to 1249.

IOVA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Iovance Biotherapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IOVA Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 6.79 % 11.55 % -10.94 % 0.31 % 34.04 %
Y / Y Cost of Sales Growth 24.82 % -10.81 % -0.51 % -5.34 % 22.08 %
Inventory Turnover Ratio (TTM) 3.21 3.09 3.27 3.17 3.21
IOVA's Total Ranking # 1249 # 995 # 746 # 506 #
Average inventory processing period 114 118 112 115 114
Seq. Inventory Growth -0.66 % -4.77 % 12.96 % -0.06 % 3.77 %
Seq. Cost of Sales Growth 10.17 % 2.58 % -1.42 % 12.04 % -21.28 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 122
Overall Market # 1249

Inventory Turnover Ratio Statistics
High Average Low
3.41 3.05 1.54
(Dec 31 2024)   (Mar 31 2024)



IOVA Company Profile >> Back to IOVA Efficiency Comparisons >> Compare IOVA Inventory Turnover Ratio to its Competitors

Financial Statements
Iovance Biotherapeutics Inc 's Inventories $ 55 Millions Visit IOVA's Balance sheet
Iovance Biotherapeutics Inc 's Cost of Revenues TTM $ 177 Millions Visit IOVA's Income Statement
What are IOVA's Sales? Visit IOVA's Sales by Segment

Other Inventory Turnover Ratios
Iovance Biotherapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IOVA's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IOVA's Competitors
Inventory Turnover Ratio for IOVA's Suppliers
Inventory Turnover Ratio for IOVA's Customers

You may also want to know
IOVA's Sales Growth Rates IOVA's Pe Price to earnings ratio IOVA's Receivables Turnover Ratio IOVA's Stock Quote
IOVA's Net Income Growth Rates IOVA's Ps Price to Sales ratio IOVA's Sales per Employee IOVA's Asset Turnover Ratio
IOVA's Net Margin IOVA's Pb Price to Book ratio IOVA's Financial Strength Ratios IOVA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions

Date modified: 2026-11-09T06:45:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.